NCT04961424 is a clinical trial in Spinal Epidural Hematoma, sponsored by Peking University Third Hospital.

Who is sponsoring NCT04961424?

NCT04961424 is sponsored by Peking University Third Hospital.

What condition does NCT04961424 study?

NCT04961424 studies Spinal Epidural Hematoma, Thoracic Surgery.

Is NCT04961424 still recruiting?

NCT04961424 is currently completed. Last updated 14 July 2021.

Last reviewed 2021-07-14 · How we verify

NCT04961424

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Postoperative Spinal Epidural Hematoma Following Posterior Thoracic Spinal Surgery in a Single Institute

Completed Last updated 14 July 2021

What this trial tests

trial in Spinal Epidural Hematoma in 22 participants. Completed in 18 February 2021.

Timeline

19 February 2020

Primary endpoint
19 February 2020

18 February 2021

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	22
Start date	19 February 2020
Primary completion	19 February 2020
Estimated completion	18 February 2021
Sites	1 location across China

Conditions studied

Spinal Epidural Hematoma — all drugs for Spinal Epidural Hematoma →
Thoracic Surgery — all drugs for Thoracic Surgery →

Sponsor

Peking University Third Hospital

Who can join

Eligibility, any sex, with Spinal Epidural Hematoma or Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective, observational single-center study. The studies is to investigate the incidence of posterior epidural spinal hematoma(PSEH) and recognize the risk factors for it in a cohort of patients undergoing posterior thoracic surgery in isolation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04961424 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 14 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing